Hennion & Walsh Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.61M	Buy	103,290 +2,561	+3%	+$56.3K	0.07%	319
2026 Q1	$2.24M	Sell	100,729 -3,117	-3%	-$74.5K	0.08%	319
2025 Q4	$2.77M	Sell	103,846 -27,885	-21%	-$666K	0.1%	275
2025 Q3	$2.81M	Sell	131,731 -8,390	-6%	-$198K	0.1%	260
2025 Q2	$3.02M	Buy	140,121 +9,060	+7%	+$168K	0.12%	218
2025 Q1	$2.18M	Buy	131,061 +27,736	+27%	+$504K	0.1%	254
2024 Q4	$1.9M	Buy	103,325 +7,491	+8%	+$121K	0.09%	301
2024 Q3	$1.47M	Sell	95,834 -6,643	-6%	-$111K	0.07%	361
2024 Q2	$1.67M	Sell	102,477 -40,521	-28%	-$654K	0.09%	293
2024 Q1	$2.64M	Buy	142,998 +27,871	+24%	+$691K	0.14%	201
2023 Q4	$3.6M	Sell	115,127 -24,912	-18%	-$595K	0.21%	127
2023 Q3	$2.92M	Sell	140,039 -11,068	-7%	-$301K	0.19%	134
2023 Q2	$3.62M	Sell	151,107 -60,670	-29%	-$1.35M	0.21%	116
2023 Q1	$3.99M	Buy	211,777 +3,028	+1%	+$57.7K	0.24%	102
2022 Q4	$3.32M	Buy	208,749 +8,717	+4%	+$136K	0.21%	129
2022 Q3	$3.27M	Buy	200,032 +2,117	+1%	+$34.3K	0.22%	123
2022 Q2	$2.79M	Sell	197,915 -13,577	-6%	-$253K	0.17%	154
2022 Q1	$5.12M	Buy	211,492 +21,337	+11%	+$516K	0.27%	95
2021 Q4	$4.44M	Buy	190,155 +8,692	+5%	+$175K	0.22%	126
2021 Q3	$3.01M	Buy	181,463 +13,364	+8%	+$258K	0.16%	188
2021 Q2	$4.1M	Buy	168,099 +8,975	+6%	+$203K	0.22%	118
2021 Q1	$4.11M	Buy	+159,124	New	+$7M	0.25%	105

Other funds holding ACAD